BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-215@pharmaconomics
DTSTAMP:20260707T034933Z
DTSTART;VALUE=DATE:20260531
DTEND;VALUE=DATE:20260601
SUMMARY:CING PDUFA — CTx-1301
DESCRIPTION:The FDA's approval decision on CTx-1301 for ADHD is due May 31\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1862150/000149315226022881/ex99-1.htm\n\nTrack it: https://www.pharmaconomics.com/e/215
URL:https://www.pharmaconomics.com/e/215
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CING catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR